Head to head
DRDGOLD vs Newmont
Side-by-side on the measures that matter, with a plain-English read. Full detail: DRD · NEM
DRD
DRDGOLD
20.02-3.19%
1-year price shape — -22% over the period
Quant Rating D · 15/100
vs
NEM
Newmont
94.68-5.37%
1-year price shape — +17% over the period
Quant Rating D · 52/100
1-year performance, rebased to 100
DRDGOLD edges it on the scoreable measures. DRDGOLD trades cheapest on trailing earnings; DRDGOLD pays the highest dividend yield.
| DRD | NEM | |
|---|---|---|
| Snapshot | ||
| Sector | Gold | Gold |
| Last price | 20.02 | 94.68 |
| Change today | -3.19% | -5.37% |
| 1-year return | -22.1% | +16.5% |
| Market cap | $1.74B | $98.39B |
| 52-week range | 18.94 – 37.95 | 82.34 – 135.01 |
| Valuation | ||
| P/E (TTM) | 7.17 | 10.98 |
| P/E percentile, own 5-yr range | 17th | 50th |
| P/B | 2.39 | 2.76 |
| Dividend yield | 2.76% | 1.09% |
| Profitability & growth | ||
| EPS (TTM) | 2.79 | 6.39 |
| Net profit (TTM) | $242.64M | $6.64B |
| Revenue (TTM) | $2.11B | $26.61B |
| Provider revenue period date | 2015-06-29 | 2026-09-29 |
| Revenue growth (YoY) | +25.2% | +15.2% |
| Gross margin | 53.5% | 59.7% |
| Operating margin | 51.4% | 55.6% |
| Net margin | 38.1% | 34.7% |
| Free cash flow (TTM) | $192.70M | $10.07B |
| Provider cash-flow period date | 2015-06-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 77.4% | 80.9% |
| Insider activity (12mo) | 19 buy / 30 sell | 20 buy / 27 sell |
| Short interest (% of float) | 1.4% | 1.7% |
| Analyst consensus | 100% buy (1) | 93% buy / 7% hold (14) |
| Analyst price target | $35 (+75%) | $140 (+48%) |
| StockVane view | ||
| StockVane Quant Rating | D (15) | D (52) |
| Company | ||
| Employees | 3,975 | 44,100 |
| Founded | 1895 | 1921 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.